Published in Am J Respir Cell Mol Biol on May 01, 2016
Role for phospholipid acyl chains and cholesterol in pulmonary infections and inflammation. J Leukoc Biol (2016) 0.75
Metabolomics analysis reveals that benzo[a]pyrene, a component of PM2.5, promotes pulmonary injury by modifying lipid metabolism in a phospholipase A2-dependent manner in vivo and in vitro. Redox Biol (2017) 0.75
Irgm1 coordinately regulates autoimmunity and host defense at select mucosal surfaces. JCI Insight (2017) 0.75
Effect of acute ozone exposure on the lung metabolomes of obese and lean mice. PLoS One (2017) 0.75
Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell (2008) 6.37
Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science (2008) 5.04
LIPID MAPS online tools for lipid research. Nucleic Acids Res (2007) 3.97
Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem (1997) 3.91
Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest (2000) 3.51
Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc Natl Acad Sci U S A (1999) 2.85
Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae. J Exp Med (1982) 2.79
Group B streptococcal beta-hemolysin expression is associated with injury of lung epithelial cells. Infect Immun (1996) 2.25
C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids. Proc Natl Acad Sci U S A (2002) 2.20
Oxysterols direct immune cell migration via EBI2. Nature (2011) 2.19
Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2. Arterioscler Thromb Vasc Biol (2003) 2.15
25-Hydroxycholesterol secreted by macrophages in response to Toll-like receptor activation suppresses immunoglobulin A production. Proc Natl Acad Sci U S A (2009) 2.14
Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol. Immunity (2012) 2.13
Lung environment determines unique phenotype of alveolar macrophages. Am J Physiol Lung Cell Mol Physiol (2009) 2.10
Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease. Annu Rev Med (2010) 2.05
Dynamic regulation of cardiolipin by the lipid pump Atp8b1 determines the severity of lung injury in experimental pneumonia. Nat Med (2010) 2.05
Generation and biological activities of oxidized phospholipids. Antioxid Redox Signal (2010) 2.04
The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral response. Immunity (2012) 1.96
Oxysterols direct B-cell migration through EBI2. Nature (2011) 1.94
Identification of prostaglandin E2 receptor subtype 2 as a receptor activated by OxPAPC. Circ Res (2006) 1.89
Chronic ethanol ingestion impairs alveolar type II cell glutathione homeostasis and function and predisposes to endotoxin-mediated acute edematous lung injury in rats. J Clin Invest (1998) 1.82
Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med (1996) 1.79
The TLR4 antagonist Eritoran protects mice from lethal influenza infection. Nature (2013) 1.78
Group B streptococcal beta-hemolysin/cytolysin promotes invasion of human lung epithelial cells and the release of interleukin-8. J Infect Dis (2002) 1.68
Cholesterol 25-hydroxylase production by dendritic cells and macrophages is regulated by type I interferons. J Leukoc Biol (2010) 1.61
The molecular basis of pulmonary alveolar proteinosis. Clin Immunol (2010) 1.54
Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy. J Clin Invest (2008) 1.54
Protection against inhaled oxidants through scavenging of oxidized lipids by macrophage receptors MARCO and SR-AI/II. J Clin Invest (2007) 1.52
Rates of sterol synthesis and uptake in the major organs of the rat in vivo. J Lipid Res (1981) 1.51
Oxidized phospholipid inhibition of toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition. J Biol Chem (2008) 1.48
Oxidized phospholipids: from molecular properties to disease. Biochim Biophys Acta (2007) 1.47
Oxysterol gradient generation by lymphoid stromal cells guides activated B cell movement during humoral responses. Immunity (2012) 1.44
Deletion of the transmembrane transporter ABCG1 results in progressive pulmonary lipidosis. J Biol Chem (2006) 1.42
Hypercholesterolemia impairs immunity to tuberculosis. Infect Immun (2008) 1.39
A comparison of the molecular species compositions of mammalian lung surfactant phospholipids. Comp Biochem Physiol A Mol Integr Physiol (2001) 1.38
Inflammation. 25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon. Science (2014) 1.33
Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection. Proc Natl Acad Sci U S A (2009) 1.33
Loss of ABCG1 results in chronic pulmonary inflammation. J Immunol (2008) 1.32
Anti-inflammatory effects of phosphatidylcholine. J Biol Chem (2007) 1.29
A critical role for ABCG1 in macrophage inflammation and lung homeostasis. J Immunol (2008) 1.28
Altered airway surfactant phospholipid composition and reduced lung function in asthma. J Appl Physiol (1985) (2000) 1.24
Surfactant alteration and replacement in acute respiratory distress syndrome. Respir Res (2001) 1.23
The chemotactic receptor EBI2 regulates the homeostasis, localization and immunological function of splenic dendritic cells. Nat Immunol (2013) 1.22
Pulmonary abnormalities due to ABCA1 deficiency in mice. Am J Physiol Lung Cell Mol Physiol (2005) 1.21
D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes. Circulation (2004) 1.20
Anionic pulmonary surfactant phospholipids inhibit inflammatory responses from alveolar macrophages and U937 cells by binding the lipopolysaccharide-interacting proteins CD14 and MD-2. J Biol Chem (2009) 1.20
Oxidative lipidomics of hyperoxic acute lung injury: mass spectrometric characterization of cardiolipin and phosphatidylserine peroxidation. Am J Physiol Lung Cell Mol Physiol (2010) 1.19
Oxidized phospholipids derived from ozone-treated lung surfactant extract reduce macrophage and epithelial cell viability. Chem Res Toxicol (2002) 1.17
Appraising the apoptotic mimicry model and the role of phospholipids for poxvirus entry. Proc Natl Acad Sci U S A (2009) 1.15
D-4F, an apoA-1 mimetic, decreases airway hyperresponsiveness, inflammation, and oxidative stress in a murine model of asthma. J Lipid Res (2010) 1.14
Phosphatidylinositides bind to plasma membrane CD14 and can prevent monocyte activation by bacterial lipopolysaccharide. J Biol Chem (1998) 1.13
Formation of biologically active oxysterols during ozonolysis of cholesterol present in lung surfactant. J Biol Chem (2004) 1.13
Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia. Am J Respir Crit Care Med (2001) 1.13
Circulating oxidized LDL: a biomarker and a pathogenic factor. Curr Opin Lipidol (2009) 1.12
Effects of liver X receptor agonist treatment on pulmonary inflammation and host defense. J Immunol (2008) 1.11
Characterization of the extracellular bactericidal factors of rat alveolar lining material. J Clin Invest (1984) 1.10
Treponemal phospholipids inhibit innate immune responses induced by pathogen-associated molecular patterns. J Biol Chem (2003) 1.08
Inhibition of LPS- and CpG DNA-induced TNF-alpha response by oxidized phospholipids. Am J Physiol Lung Cell Mol Physiol (2003) 1.08
A role for neutral sphingomyelinase activation in the inhibition of LPS action by phospholipid oxidation products. J Lipid Res (2006) 1.08
Elimination of cholesterol as cholestenoic acid in human lung by sterol 27-hydroxylase: evidence that most of this steroid in the circulation is of pulmonary origin. J Lipid Res (1999) 1.08
Oxidized phospholipid-induced inflammation is mediated by Toll-like receptor 2. Free Radic Biol Med (2011) 1.07
Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis (2006) 1.07
Oxidized phospholipids are more potent antagonists of lipopolysaccharide than inducers of inflammation. J Immunol (2010) 1.06
The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils. J Exp Med (2013) 1.06
Crosstalk between reverse cholesterol transport and innate immunity. Trends Endocrinol Metab (2012) 1.04
25-Hydroxycholesterol acts as an amplifier of inflammatory signaling. Proc Natl Acad Sci U S A (2014) 1.04
Phospholipids inhibit lipopolysaccharide (LPS)-induced cell activation: a role for LPS-binding protein. J Immunol (2005) 1.03
Surfactant lipids regulate LPS-induced interleukin-8 production in A549 lung epithelial cells by inhibiting translocation of TLR4 into lipid raft domains. J Lipid Res (2009) 1.03
Surfactant phospholipid metabolism. Biochim Biophys Acta (2012) 1.03
EBI2-mediated bridging channel positioning supports splenic dendritic cell homeostasis and particulate antigen capture. Elife (2013) 1.03
Oxidative lipidomics of γ-radiation-induced lung injury: mass spectrometric characterization of cardiolipin and phosphatidylserine peroxidation. Radiat Res (2011) 1.02
Binding of adenovirus capsid to dipalmitoyl phosphatidylcholine provides a novel pathway for virus entry. J Virol (2003) 1.01
Phosphatidylglycerol suppresses influenza A virus infection. Am J Respir Cell Mol Biol (2011) 1.01
Diseases of pulmonary surfactant homeostasis. Annu Rev Pathol (2015) 1.01
Apoptosis induced by ozone and oxysterols in human alveolar epithelial cells. Free Radic Biol Med (2010) 0.99
Pulmonary surfactant phosphatidylglycerol inhibits Mycoplasma pneumoniae-stimulated eicosanoid production from human and mouse macrophages. J Biol Chem (2011) 0.99
Induction of macrophage scavenger receptor MARCO in nonalcoholic steatohepatitis indicates possible involvement of endotoxin in its pathogenic process. Int J Exp Pathol (2004) 0.98
Dyslipidemia induces opposing effects on intrapulmonary and extrapulmonary host defense through divergent TLR response phenotypes. J Immunol (2010) 0.98
Global phospholipidomics analysis reveals selective pulmonary peroxidation profiles upon inhalation of single-walled carbon nanotubes. ACS Nano (2011) 0.97
Enhancement of enveloped virus entry by phosphatidylserine. J Virol (2005) 0.96
Role of cholesterol in the biophysical dysfunction of surfactant in ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol (2009) 0.95
Oxidized lipoproteins inhibit surfactant phosphatidylcholine synthesis via calpain-mediated cleavage of CTP:phosphocholine cytidylyltransferase. J Biol Chem (2003) 0.95
Oxysterols inhibit phosphatidylcholine synthesis via ERK docking and phosphorylation of CTP:phosphocholine cytidylyltransferase. J Biol Chem (2005) 0.95
Pulmonary T cell activation in response to chronic particulate air pollution. Am J Physiol Lung Cell Mol Physiol (2011) 0.95
Oxidized phospholipids impair pulmonary antibacterial defenses: evidence in mice exposed to cigarette smoke. Biochem Biophys Res Commun (2012) 0.94
HDL is the major source of vitamin E for type II pneumocytes. Free Radic Biol Med (1999) 0.93
ATP binding cassette transporter G1 deletion induces IL-17-dependent dysregulation of pulmonary adaptive immunity. J Immunol (2012) 0.93
Novel keto-phospholipids are generated by monocytes and macrophages, detected in cystic fibrosis, and activate peroxisome proliferator-activated receptor-γ. J Biol Chem (2012) 0.92
Low density lipoprotein- and high density lipoprotein-mediated signal transduction and exocytosis in alveolar type II cells. Proc Natl Acad Sci U S A (1993) 0.91
Antioxidant responses to acute ozone challenge in the healthy human airway. Inhal Toxicol (2009) 0.90
Surfactant cholesterol metabolism of the isolated perfused rat lung. Biochim Biophys Acta (1979) 0.90
Effect of rat alveolar lining material on macrophage receptors. J Immunol (1983) 0.90
Phospholipid oxidation generates potent anti-inflammatory lipid mediators that mimic structurally related pro-resolving eicosanoids by activating Nrf2. EMBO Mol Med (2015) 0.89
Surfactant and its role in the pathobiology of pulmonary infection. Microbes Infect (2011) 0.88
Targeting liver X receptors in inflammation. Expert Opin Ther Targets (2013) 0.88
Phosphatidylglycerol provides short-term prophylaxis against respiratory syncytial virus infection. J Lipid Res (2013) 0.88
Alveolar macrophage depletion is associated with increased surfactant pool sizes in adult rats. J Appl Physiol (1985) (2007) 0.88
Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis. Eur Respir J (1999) 0.88
Pseudomonas aeruginosa and sPLA2 IB stimulate ABCA1-mediated phospholipid efflux via ERK-activation of PPARalpha-RXR. Biochem J (2007) 0.87